Search Prime Grants

HT9425261E234

Project Grant

Overview

Grant Description
Targeting tumor-specific isoforms of AURKA in pancreatic cancer with splice-switching antisense oligonucleotides
Awardee
Cold Spring Harbor Laboratory
Funding Goals
IMPACT AWARD PEER REVIEWED CANCER RESEARCH PROGRAM
Grant Program (CFDA)
12.420 - Military Medical Research and Development
Awarding / Funding Agency
Defense Health Agency (DHA) [DoD]
Place of Performance
Cold Spring Harbor, New York 117240001 United States
Geographic Scope
Single Zip Code
Related Opportunity
DOD Peer Reviewed Cancer, Impact Award (HT942525PRCRPIPA)
Cold Spring Harbor Laboratory was awarded Project Grant HT9425261E234 worth $1,399,995 from Defense Health Agency in July 2026 with work to be completed primarily in Cold Spring Harbor New York United States. The grant has a duration of 3 years and was awarded through assistance program 12.420 Military Medical Research and Development. The Project Grant was awarded through grant opportunity DOD Peer Reviewed Cancer, Impact Award.

Status
(Ongoing)

Last Modified 5/28/26

Period of Performance
7/1/26
Start Date
6/30/29
End Date
0% Complete

Funding Split
$1.4M
Federal Obligation
$0.0
Non-Federal Obligation
$1.4M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to HT9425261E234

Additional Detail

Award ID FAIN
HT9425261E234
SAI Number
None
Award ID URI
None
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Other
Awarding Office
HT9425 ARMY MED RES ACQ ACTIVITY
Funding Office
HT0989 CONG DIR MED RES PRGM / CDMRP - MM
Awardee UEI
GV31TMFLPY88
Awardee CAGE
0DHK5
Performance District
NY-03
Senators
Kirsten Gillibrand
Charles Schumer
Modified: 5/28/26